Article Text

Download PDFPDF
Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma
  1. A V Appelboam1,
  2. P I Dargan2,
  3. J Knighton1
  1. 1Queen Alexandra Hospital, Portsmouth, UK
  2. 2National Poisons Information Service, London, UK
  1. Correspondence to:
 Dr A Appelboam, Department of Anaesthetics, Torbay Hospital, Torquay, Devon TQ2 7AA;
 andy.bec{at}virgin.net

Abstract

Paracetamol overdose is a common reason for presentation to the emergency department and N-acetylcysteine is frequently used in the treatment of toxic paracetamol ingestions. Adverse reactions to N-acetylcysteine are common though usually mild and easily treated. Serious reactions to N-acetylcysteine however, are rare and there have been no previous reported fatalities with its therapeutic use. This report describes the case of a 40 year old brittle asthmatic patient who died after treatment with intravenous N-acetylcysteine. Asthma is a risk factor for adverse reactions to N-acetylcysteine and special caution should be exercised in its use in brittle asthmatic patients.

  • paracetamol
  • asthma
  • N-acetylcysteine

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes